Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
Maria Røed Skårderud, Anne Polk, Kirsten Kjeldgaard Vistisen, Finn Ole Larsen,
Dorte Lisbet Nielsen
Department of Clinical Medicine
30
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Metastatic Colorectal Cancer (mCRC)
100%
Placebo
42%
Adverse Events
28%
Meta-analysis
28%
Progression-free Survival
28%
Hazard Ratio
28%
Overall Survival
28%
Randomized Phase III Trial
28%
Embase
14%
Molecular Biomarkers
14%
Conference Abstracts
14%
Colorectal Cancer
14%
Survival Benefit
14%
Multi-targeted Tyrosine Kinase Inhibitors
14%
Previously Treated
14%
PubMed
14%
Patient Selection
14%
Nonrandomized Studies
14%
Treatment Options
14%
Treatment Effect
14%
Phase II Trial
14%
Clinical Biomarkers
14%
Clinical Data
14%
Hypertension
14%
Overall Survival Progression-free Survival
14%
Pharmacology, Toxicology and Pharmaceutical Science
Regorafenib
100%
Hand Foot Syndrome
14%